Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 10 studies | 30% ± 14% | |
endothelial cell | 9 studies | 30% ± 13% | |
glutamatergic neuron | 8 studies | 42% ± 24% | |
oligodendrocyte | 8 studies | 30% ± 8% | |
interneuron | 7 studies | 39% ± 20% | |
GABAergic neuron | 7 studies | 40% ± 19% | |
astrocyte | 7 studies | 30% ± 9% | |
macrophage | 6 studies | 28% ± 5% | |
neuron | 5 studies | 35% ± 15% | |
microglial cell | 5 studies | 24% ± 7% | |
erythrocyte | 5 studies | 44% ± 22% | |
epithelial cell | 4 studies | 29% ± 12% | |
ciliated cell | 4 studies | 20% ± 7% | |
GABAergic interneuron | 3 studies | 23% ± 8% | |
granule cell | 3 studies | 21% ± 1% | |
endothelial cell of lymphatic vessel | 3 studies | 20% ± 2% | |
transit amplifying cell | 3 studies | 32% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 40% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3965.35 | 1445 / 1445 | 100% | 49.90 | 183 / 183 |
intestine | 100% | 4006.92 | 966 / 966 | 100% | 36.58 | 527 / 527 |
lung | 100% | 4231.82 | 578 / 578 | 100% | 40.58 | 1155 / 1155 |
thymus | 100% | 5435.91 | 653 / 653 | 100% | 51.67 | 605 / 605 |
brain | 100% | 4630.65 | 2639 / 2642 | 100% | 54.80 | 705 / 705 |
breast | 100% | 4466.34 | 459 / 459 | 100% | 47.00 | 1116 / 1118 |
prostate | 100% | 4077.15 | 245 / 245 | 100% | 31.80 | 501 / 502 |
skin | 100% | 5395.70 | 1809 / 1809 | 100% | 62.63 | 471 / 472 |
uterus | 100% | 5243.79 | 170 / 170 | 100% | 43.65 | 458 / 459 |
ovary | 100% | 5614.74 | 180 / 180 | 100% | 35.10 | 429 / 430 |
stomach | 100% | 3280.77 | 359 / 359 | 100% | 40.74 | 285 / 286 |
bladder | 100% | 4124.90 | 21 / 21 | 100% | 35.89 | 502 / 504 |
pancreas | 100% | 2488.75 | 328 / 328 | 99% | 32.50 | 177 / 178 |
adrenal gland | 100% | 4519.20 | 258 / 258 | 99% | 35.88 | 228 / 230 |
kidney | 100% | 3814.65 | 89 / 89 | 99% | 33.58 | 891 / 901 |
liver | 100% | 1837.46 | 225 / 226 | 81% | 15.25 | 327 / 406 |
adipose | 100% | 4308.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4483.59 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 41.31 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.74 | 29 / 29 |
muscle | 100% | 3669.53 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4600.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.26 | 1 / 1 |
peripheral blood | 99% | 3832.64 | 922 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 2941.37 | 836 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006611 | Biological process | protein export from nucleus |
GO_0005643 | Cellular component | nuclear pore |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005049 | Molecular function | nuclear export signal receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
Gene name | XPO7 |
Protein name | Exportin 7 Exportin-7 (Exp7) (Ran-binding protein 16) |
Synonyms | KIAA0745 RANBP16 |
Description | FUNCTION: Mediates the nuclear export of proteins (cargos) with broad substrate specificity. In the nucleus binds cooperatively to its cargo and to the GTPase Ran in its active GTP-bound form. Docking of this trimeric complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, disassembling of the complex and hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause release of the cargo from the export receptor. XPO7 then return to the nuclear compartment and mediate another round of transport. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. . |
Accessions | E7ESC6 H0YBE1 ENST00000521303.5 ENST00000433566.8 ENST00000517551.2 E5RIW1 Q9UIA9 ENST00000252512.14 |